First Trust Nasdaq Pharmaceuticals ETF
Not enough financial coverage to compute a composite score for FTXH. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.ftportfolios.com/Retail/Etf/EtfSummary.aspx?Ticker=FTXH
The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to generate performance results 95% correlated to that of the Nasdaq US Smart Pharmaceuticals Index.
- IPO
- 2016
- HQ
- Wheaton, IL, US
Price Chart
Valuation
- Market Cap
- $34.16M
- Div Yield
- 1.23%
Performance & Tape
- 52W High
- $35.61
- 52W Low
- $24.86
- 50D MA
- $33.97
- 200D MA
- $31.89
- Beta
- 0.50
- Avg Volume
- 6.72K
Get TickerSpark's AI analysis on FTXH
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our FTXH Coverage
We haven't published any research on FTXH yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate FTXH Report →